Revolutionising triple negative breast cancer treatment

Triple negative breast cancer is an aggressive disease with a greater likelihood of spreading around the body and recurring within five years than other breast cancers. Join us to hear from Associate Professor Christine Chaffer. Her team has found that an experimental drug, seviteronel, combined with chemotherapy, could be twice as effective in reducing the size of tumours than chemotherapy alone. Spaces are limited in the Auditorium so registration is essential.
You can register to attend one of our future public seminars here: www.garvan.org.au/tours-event...
Support this research here: www.garvan.org.au/support-us/...
#garvan #medicalresearch #breastcancer

[@silversurfer2140]

This sounds really hopeful .

[@LilyLChew]

Is there a brand name for this drug? Please spell the drug name. Is it available in the US?

[@gentlemensknowing733]

Hi.
Will this medicine work if someone is having Androgen negative TNBC breast Cancer?